Background Patients with prostate cancer who have high-risk biochemical recurrence have
an increased risk of progression. The efficacy and safety of enzalutamide plus androgen …

Gynecomastia is a relatively common disorder. Its causes range from benign physiological
processes to rare neoplasms. To diagnose the etiology of the gynecomastia, the clinician …

Newer therapeutic strategies on rise for Prostate Cancer stem cells due to current
standardized therapies for prostate cancer including chemotherapy, androgen deprivation …

The primary reason for the utilization of any screening exam should be that the procedure
detects the early stages of a pathologic condition and allows for early intervention, thereby …

Introduction Enzalutamide, a second-generation androgen receptor inhibitor, is indicated for
the treatment of metastatic disease, as well as in the treatment of non-metastatic castration …

Purpose: While active surveillance is the preferred management for most men with low-risk
prostate cancer, a subset may harbor more aggressive disease. In this review we examine …

Background There is an unmet clinical need for interventions to prevent disease progression
in patients with localized prostate cancer on active surveillance (AS). Objective To determine …

Prostate cancers adapt to androgen receptor (AR) pathway inhibitors and progress to
castration resistance due to ongoing AR expression and function. To counter this, we …

Context Active surveillance (AS) is a standard of care for patients with low-risk and selected
intermediate-risk prostate cancer (PCa). Nevertheless, there is a lack of summary evidence …

In Reply Active surveillance (AS) is the preferred management strategy for low-risk prostate
cancer. While AS rates are increasing in clinical practice, its adoption remains suboptimal …